3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
64
Burkitt Lymphoma
10
Recurrence
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, B-Cell
4
Carcinoma, Non-Small-Cell Lung
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms, Plasma Cell
3
Lymphoma, Non-Hodgkin
3
Smoldering Multiple Myeloma
2
Rectal Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Immunoglobulin Light-chain Amyloidosis
2
Down Syndrome
2
beta-Thalassemia
1
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thalassemia
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatic Neoplasms
1
Plasmacytoma
1
Interventions
Specimen Handling
4
Biopsy
4
Whole-Body Irradiation
3
Mycophenolic Acid
3
Cyclosporine
3
Cyclophosphamide
3
fludarabine phosphate
2
decitabine and cedazuridine drug combination
2
Sirolimus
2
Melphalan
2
Granulocyte Colony-Stimulating Factor
2
Busulfan
2
venetoclax
1
tocilizumab
1
ruxolitinib
1
peginterferon alfa-2b
1
iadademstat
1
fludarabine
1
Tacrolimus
1
Rituximab
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Idarubicin
1
Hyperbaric Oxygenation
1
Filgrastim
1
Etoposide
1
Cytarabine
1
Cyclosporins
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
Dexamethasone
×
30 days
×
Clear all
No trials found.